168 related articles for article (PubMed ID: 36267507)
21. Prognostic role of transferrin saturation in heart failure patients.
Campodonico J; Nicoli F; Motta I; Migone De Amicis M; Bonomi A; Cappellini M; Agostoni P
Eur J Prev Cardiol; 2021 Dec; 28(15):1639-1646. PubMed ID: 33619543
[TBL] [Abstract][Full Text] [Related]
22. Iron deficiency in new onset heart failure: association with clinical factors and quality of life.
Cabrera CC; Ekström M; Tornvall P; Löfström U; Frisk C; Linde C; Hage C; Persson H; Eriksson MJ; Wallén H; Persson B; Lyngå P
ESC Heart Fail; 2024 May; ():. PubMed ID: 38803153
[TBL] [Abstract][Full Text] [Related]
23. Monitoring of iron status in patients with heart failure.
Jankowska EA; Tkaczyszyn M; Drozd M; Ponikowski P
Eur Heart J Suppl; 2019 Dec; 21(Suppl M):M32-M35. PubMed ID: 31908613
[TBL] [Abstract][Full Text] [Related]
24. Definition of Iron Deficiency Based on the Gold Standard of Bone Marrow Iron Staining in Heart Failure Patients.
Grote Beverborg N; Klip IT; Meijers WC; Voors AA; Vegter EL; van der Wal HH; Swinkels DW; van Pelt J; Mulder AB; Bulstra SK; Vellenga E; Mariani MA; de Boer RA; van Veldhuisen DJ; van der Meer P
Circ Heart Fail; 2018 Feb; 11(2):e004519. PubMed ID: 29382661
[TBL] [Abstract][Full Text] [Related]
25. Iron therapy and severe arrhythmias in HFrEF: rationale, study design, and baseline results of the RESAFE-HF trial.
Bakogiannis C; Mouselimis D; Tsarouchas A; Papadopoulos CE; Theofillogiannakos EK; Lechat E; Antoniadis AP; Pagourelias ED; Kelemanis I; Tzikas S; Fragakis N; Efthimiadis GK; Karamitsos TD; Doumas M; Vassilikos VP
ESC Heart Fail; 2023 Apr; 10(2):1184-1192. PubMed ID: 36647691
[TBL] [Abstract][Full Text] [Related]
26. Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status.
Comín-Colet J; Enjuanes C; González G; Torrens A; Cladellas M; Meroño O; Ribas N; Ruiz S; Gómez M; Verdú JM; Bruguera J
Eur J Heart Fail; 2013 Oct; 15(10):1164-72. PubMed ID: 23703106
[TBL] [Abstract][Full Text] [Related]
27. Should we use ferritin in the diagnostic criteria of iron deficiency in heart failure patients?
Gentil JRS; Fabricio CG; Tanaka DM; Suen VMM; Volpe GJ; Marchini JS; Simões MV
Clin Nutr ESPEN; 2020 Oct; 39():119-123. PubMed ID: 32859304
[TBL] [Abstract][Full Text] [Related]
28. Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure.
Graham FJ; Masini G; Pellicori P; Cleland JGF; Greenlaw N; Friday J; Kazmi S; Clark AL
Eur J Heart Fail; 2022 May; 24(5):807-817. PubMed ID: 34050582
[TBL] [Abstract][Full Text] [Related]
29. Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia.
Anker SD; Colet JC; Filippatos G; Willenheimer R; Dickstein K; Drexler H; Lüscher TF; Mori C; von Eisenhart Rothe B; Pocock S; Poole-Wilson PA; Ponikowski P;
Eur J Heart Fail; 2009 Nov; 11(11):1084-91. PubMed ID: 19875408
[TBL] [Abstract][Full Text] [Related]
30. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
31. Iron deficiency is an independent risk factor of increased myocardial energy expenditure in chronic heart failure patients.
Lin F; Huang Y; An D; Zhan Q; Wang P; Lai W; Zeng Q; Dong S; Ren H; Xu D
Ann Palliat Med; 2021 Dec; 10(12):12061-12071. PubMed ID: 35016401
[TBL] [Abstract][Full Text] [Related]
32. Iron Deficiency Impacts Diastolic Function, Aerobic Exercise Capacity, and Patient Phenotyping in Heart Failure With Preserved Ejection Fraction: A Subanalysis of the OptimEx-Clin Study.
Gevaert AB; Mueller S; Winzer EB; Duvinage A; Van de Heyning CM; Pieske-Kraigher E; Beckers PJ; Edelmann F; Wisløff U; Pieske B; Adams V; Halle M; Van Craenenbroeck EM;
Front Physiol; 2021; 12():757268. PubMed ID: 35222057
[TBL] [Abstract][Full Text] [Related]
33. Iron deficiency in heart failure patients: the French CARENFER prospective study.
Cohen-Solal A; Philip JL; Picard F; Delarche N; Taldir G; Gzara H; Korichi A; Trochu JN; Cacoub P;
ESC Heart Fail; 2022 Apr; 9(2):874-884. PubMed ID: 35170249
[TBL] [Abstract][Full Text] [Related]
34. Rationale and design of the CONFIRM-HF study: a double-blind, randomized, placebo-controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency.
Ponikowski P; van Veldhuisen DJ; Comin-Colet J; Ertl G; Komajda M; Mareev V; McDonagh TA; Parkhomenko A; Tavazzi L; Levesque V; Mori C; Roubert B; Filippatos G; Ruschitzka F; Anker SD
ESC Heart Fail; 2014 Sep; 1(1):52-58. PubMed ID: 28834668
[TBL] [Abstract][Full Text] [Related]
35. Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life.
Bekfani T; Pellicori P; Morris D; Ebner N; Valentova M; Sandek A; Doehner W; Cleland JG; Lainscak M; Schulze PC; Anker SD; von Haehling S
Clin Res Cardiol; 2019 Feb; 108(2):203-211. PubMed ID: 30051186
[TBL] [Abstract][Full Text] [Related]
36. Iron deficiency and cardiovascular disease.
Savarese G; von Haehling S; Butler J; Cleland JGF; Ponikowski P; Anker SD
Eur Heart J; 2023 Jan; 44(1):14-27. PubMed ID: 36282723
[TBL] [Abstract][Full Text] [Related]
37. Iron Deficiency in Heart Failure with Reduced Ejection Fraction: Pathophysiology, Diagnosis and Treatment.
Pereira GAR; Beck-da-Silva L
Arq Bras Cardiol; 2022 Mar; 118(3):646-654. PubMed ID: 35319614
[TBL] [Abstract][Full Text] [Related]
38. Right ventricular function and iron deficiency in acute heart failure.
Miñana G; Santas E; de la Espriella R; Núñez E; Lorenzo M; Núñez G; Valero E; Bodí V; Chorro FJ; Sanchis J; Cohen-Solal A; Bayés-Genís A; Núñez J
Eur Heart J Acute Cardiovasc Care; 2021 May; 10(4):406-414. PubMed ID: 33620455
[TBL] [Abstract][Full Text] [Related]
39. Randomized Placebo-Controlled Trial of Ferric Carboxymaltose in Heart Failure With Iron Deficiency: Rationale and Design.
Mentz RJ; Ambrosy AP; Ezekowitz JA; Lewis GD; Butler J; Wong YW; De Pasquale CG; Troughton RW; O'Meara E; Rockhold FW; Garg J; Samsky MD; Leloudis D; Dugan M; Mundy LM; Hernandez AF;
Circ Heart Fail; 2021 May; 14(5):e008100. PubMed ID: 34003690
[TBL] [Abstract][Full Text] [Related]
40. Iron Deficiency: Impact on Functional Capacity and Quality of Life in Heart Failure with Preserved Ejection Fraction.
Alcaide-Aldeano A; Garay A; Alcoberro L; Jiménez-Marrero S; Yun S; Tajes M; García-Romero E; Díez-López C; González-Costello J; Mateus-Porta G; Cainzos-Achirica M; Enjuanes C; Comín-Colet J; Moliner P
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32331365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
